Evaluating Health-Related Quality-of-Life Outcomes in Patients with Congestive Heart Failure
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 15 (1) , 19-46
- https://doi.org/10.2165/00019053-199915010-00003
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- The Nottingham health profile: Subjective health status and medical consultationsPublished by Elsevier ,2002
- Multi-Attribute Preference FunctionsPharmacoEconomics, 1995
- Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.Heart, 1994
- Clinical effects of long-term administration of pimobendan in patients with moderate congestive heart failureHeart and Vessels, 1994
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendanAmerican Heart Journal, 1992
- Doxazosin for the treatment of chronic congestive heart failure: Results of a randomized double-blind and placebo-controlled studyAmerican Heart Journal, 1991
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failureCardiovascular Drugs and Therapy, 1990
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981